Sequenom CEO, Others Terminated Following Investigation
September 29, 2009
Sequenom CEO, Others Terminated Following Investigation
The clear out of several executives comes following the completion of an investigation into the mishandling of data for the firm's Down syndrome test.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- MaterniT21 Doubles Sequenom's Revenues; Firm Inks Deal with Blue Cross Blue Shield Association
May 15, 2013 / Clinical Sequencing News - Credit Suisse Upgrades Sequenom to Neutral
May 13, 2013 / GenomeWeb Daily News - Experts Weigh in on Ethical Considerations for NIPT at Biology of Genomes Panel
May 10, 2013 / GenomeWeb Daily News - Sequenom's Q1 Revenues More than Double
May 10, 2013 / GenomeWeb Daily News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News